Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Natalizumab in the Treatment of Patients With Inclusion Body Myositis

NCT02483845 is registered in ClinicalTrials.gov with Phoenix Neurological Associates, LTD as lead sponsor.

NCT NCT02483845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Natalizumab in the Treatment of Patients With Inclusion Body Myositis
Lead sponsor
Phoenix Neurological Associates, LTD
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2013
Completion date
November 30, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body myositis (ibm)